ORNL produces and supplies actinium-225, a rare isotope essential for targeted alpha therapy and vital to advancing cancer treatment research. Targeted alpha therapy attacks tumors while sparing ...
Researchers in the EHU’s Materials + Technologies Group identify two parameters to control losses, and the construction of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果